Literature DB >> 3088195

Gamma interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte/monocyte colony formation.

M Murphy, R Loudon, M Kobayashi, G Trinchieri.   

Abstract

We have shown that lymphocytes stimulated by PHA produce colony-forming unit of granulocyte/monocyte (CFU-GM)-stimulating and -inhibiting activities, IFN-gamma, and lymphotoxin (LT). IFN-gamma is necessary for inhibition of CFU-GM by PHA-conditioned medium (CM), as shown by experiments in which removal of IFN-gamma from PHA-CM abrogated inhibition. However, experiments in which rIFN-gamma was added to IFN-gamma-depleted PHA-CM revealed the presence, in PHA-CM, of other factors that act in synergy with IFN-gamma to inhibit CFU-GM. Fractionation of PHA-CM on a Sephadex G-100 column was used to separate IFN-gamma and LT. Colony-inhibiting activity was eluted in fractions that contained both IFN-gamma and LT activities, identifying LT as a factor present in PHA-CM that synergizes with IFN-gamma to inhibit CFU-GM. Treatment of PHA-CM with mAb against either IFN-gamma or LT completely abrogated the colony-inhibiting activity, demonstrating a requirement for both lymphokines in PHA-CM-induced inhibition of CFU-GM. Experiments using rIFN-gamma and preparations of purified LT confirmed that neither lymphokine alone, when added to bone marrow cells at the concentrations present in PHA-CM, strongly inhibited day 7 or day 14 CFU-GM, but that the two lymphokines, added together, behaved synergistically to inhibit CFU-GM by up to 70%. The inhibition observed using purified preparations of lymphokines shows that synergy between IFN-gamma and LT is sufficient to explain PHA-CM-induced inhibition of CFU-GM. Our findings suggest that activated T cells regulate hematopoiesis through the release of inhibitory as well as stimulatory factors, and that the simultaneous production of IFN-gamma and LT may represent a mechanism of suppression of hematopoiesis in the cases of bone marrow failure associated with the presence of activated T cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088195      PMCID: PMC2188207          DOI: 10.1084/jem.164.1.263

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  59 in total

1.  Activation of Lyt-1+ and Lyt-2+ T cell cloned lines: stimulation of proliferation, lymphokine production, and self-destruction.

Authors:  B S Conta; M B Powell; N H Ruddle
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

2.  Purification of human lymphotoxin.

Authors:  S W Russell; W Rosenau; M L Goldberg; G Kunitomi
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

3.  Differential expression of HLA-DR antigens in subsets of human CFU-GM.

Authors:  J D Griffin; K D Sabbath; F Herrmann; P Larcom; K Nichols; M Kornacki; H Levine; S A Cannistra
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

4.  Release of colony-stimulating activity from thymus-derived lymphocytes.

Authors:  F W Ruscetti; P A Chervenick
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

5.  Interaction of lactoferrin, monocytes, and T lymphocyte subsets in the regulation of steady-state granulopoiesis in vitro.

Authors:  G C Bagby; V D Rigas; R M Bennett; A A Vandenbark; H S Garewal
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

6.  Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.

Authors:  A Biondi; J A Roach; S F Schlossman; R F Todd
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

7.  Heterogeneity of human colony-forming cells.

Authors:  S Inoue; M J Ottenbreit
Journal:  Blood       Date:  1978-02       Impact factor: 22.113

8.  Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia.

Authors:  R Hoffman; E D Zanjani; J D Lutton; R Zalusky; L R Wasserman
Journal:  N Engl J Med       Date:  1977-01-06       Impact factor: 91.245

9.  Immune suppression of hematopoiesis in aplastic anemia: activity of T-gamma lymphocytes.

Authors:  A Bacigalupo; M Podestà; M C Mingari; L Moretta; M T Van Lint; A Marmont
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

10.  Heterogeneity of bone marrow-directed immune mechanisms in the pathogenesis of neutropenia of Felty's syndrome.

Authors:  N I Abdou
Journal:  Arthritis Rheum       Date:  1983-08
View more
  34 in total

1.  Frequency and cytokine profile of HPRT mutant T cells in HIV-infected and healthy donors: implications for T cell proliferation in HIV disease.

Authors:  C Paganin; D S Monos; J D Marshall; I Frank; G Trinchieri
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  Tetanus toxoid-specific T cell responses in severe combined immunodeficiency (SCID) mice reconstituted with human peripheral blood lymphocytes.

Authors:  R Somasundaram; L Jacob; D Herlyn
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

3.  Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors.

Authors:  J E Talmadge; O Bowersox; H Tribble; S H Lee; H M Shepard; D Liggitt
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

Review 4.  Cachectin/tumor necrosis factor: an endogenous mediator of shock and inflammation.

Authors:  B Beutler; A Cerami
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

5.  IFN-γ-mediated hematopoietic cell destruction in murine models of immune-mediated bone marrow failure.

Authors:  Jichun Chen; Xingmin Feng; Marie J Desierto; Keyvan Keyvanfar; Neal S Young
Journal:  Blood       Date:  2015-10-21       Impact factor: 22.113

6.  Induction of bacillus-Calmette-Guérin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell lines in vitro.

Authors:  A Thanhäuser; A Böhle; H D Flad; M Ernst; T Mattern; A J Ulmer
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

7.  Inducible expression of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and interferon-gamma in two human cytotoxic leukemic T-cell lines.

Authors:  A Cesano; D Santoli
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct

8.  Priming for high interferon-gamma production induced by interleukin-12 in both CD4+ and CD8+ T cell clones from HIV-infected patients.

Authors:  C Paganin; I Frank; G Trinchieri
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

9.  Pentoxifylline: a potent inhibitor of IL-2 and IFN-gamma biosynthesis and BCG-induced cytotoxicity.

Authors:  A Thanhäuser; N Reiling; A Böhle; K M Toellner; M Duchrow; D Scheel; C Schlüter; M Ernst; H D Flad; A J Ulmer
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

10.  Macrophage TNF-α licenses donor T cells in murine bone marrow failure and can be implicated in human aplastic anemia.

Authors:  Wanling Sun; Zhijie Wu; Zenghua Lin; Maile Hollinger; Jichun Chen; Xingmin Feng; Neal S Young
Journal:  Blood       Date:  2018-10-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.